Administration of exogenous haptoglobin improves survival in a canine model of sepsis [50], and there is some retrospective data suggesting that exogenous haptoglobin administration reduces acute kidney injury (AKI) in humans undergoing cardiac surgery [51]. Here, HP is linked to acute kidney injury.